Innoviva (INVA) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.02 per share a year ago. These figures are ...

Mochida Pharmaceutical (TSE:4534) reported a net profit margin of 5.7%, up from 4.3% a year earlier, with earnings surging 36.5% over the past year. Despite this progress, shares currently trade at ¥3 ...

Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.57 per share a year ago.

In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 ...

Public-private collaboration will also be essential to secure India’s position among the top global pharma exporters. Against ...

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 06th November 2025 from 9:30 AM to 10:15 ...

Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

Indore (Madhya Pradesh): Under the World Bank-supported ‘RAMP (Raising and Accelerating MSMEs Performance)’ scheme, the ...

The company attributed the loss to decline to inventory destocking by a key customer in a large on-patent CDMO order and slower order inflows amid inconsistent recovery in US biopharma funding.

Agentic AI was a point of emphasis on the first day of the 2025 Veeva Commercial summit held in Madrid, Spain.